1. Home
  2. MNKD vs HG Comparison

MNKD vs HG Comparison

Compare MNKD & HG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • HG
  • Stock Information
  • Founded
  • MNKD 1991
  • HG 2013
  • Country
  • MNKD United States
  • HG Bermuda
  • Employees
  • MNKD N/A
  • HG N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • HG
  • Sector
  • MNKD Health Care
  • HG
  • Exchange
  • MNKD Nasdaq
  • HG Nasdaq
  • Market Cap
  • MNKD 1.9B
  • HG 1.9B
  • IPO Year
  • MNKD 2004
  • HG 2023
  • Fundamental
  • Price
  • MNKD $6.01
  • HG $19.37
  • Analyst Decision
  • MNKD Buy
  • HG Buy
  • Analyst Count
  • MNKD 6
  • HG 7
  • Target Price
  • MNKD $8.92
  • HG $21.71
  • AVG Volume (30 Days)
  • MNKD 2.7M
  • HG 436.0K
  • Earning Date
  • MNKD 02-25-2025
  • HG 02-26-2025
  • Dividend Yield
  • MNKD N/A
  • HG N/A
  • EPS Growth
  • MNKD N/A
  • HG 537.51
  • EPS
  • MNKD 0.08
  • HG 4.48
  • Revenue
  • MNKD $267,200,000.00
  • HG $2,266,708,000.00
  • Revenue This Year
  • MNKD $45.45
  • HG N/A
  • Revenue Next Year
  • MNKD $16.45
  • HG $8.12
  • P/E Ratio
  • MNKD $75.81
  • HG $4.32
  • Revenue Growth
  • MNKD 51.35
  • HG 68.94
  • 52 Week Low
  • MNKD $3.17
  • HG $12.44
  • 52 Week High
  • MNKD $7.63
  • HG $20.71
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.75
  • HG 59.09
  • Support Level
  • MNKD $5.98
  • HG $18.11
  • Resistance Level
  • MNKD $6.32
  • HG $19.02
  • Average True Range (ATR)
  • MNKD 0.21
  • HG 0.46
  • MACD
  • MNKD -0.04
  • HG 0.05
  • Stochastic Oscillator
  • MNKD 20.55
  • HG 81.95

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About HG Hamilton Insurance Group Ltd. Class B

Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in Lloyd's, Ireland, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.

Share on Social Networks: